Profil
Aleksandra Pastrak worked as the VP-Clinical Development & Medical Officer at Transition Therapeutics, Inc. from 2012 to 2016.
Prior to that, she held other positions at the same company from 1999.
She obtained a graduate and doctorate degree from the University of Toronto and a doctorate degree from the University of Belgrade.
Anciens postes connus de Aleksandra Pastrak
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/08/2016 |
Formation de Aleksandra Pastrak
| University of Toronto | Doctorate Degree |
| University of Belgrade | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
